Delivery Order SPE2DB22D2103-SPE2DB24FR9JK
Award Date
5/20/24
Potential Completion Date
5/21/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The contract has a ceiling value of $1,920.22 and a period of performance through June 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is a delivery order valued at $1,556.64. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Micardis HCT 80-25 mg tablets. The award is not associated with a set-aside program and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4,564,235,096 Micardis HCT 40-12.5 mg tablets. The contract has a ceiling value of $1,195.96 and a performance period through April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Micardis HCT 40-12.5 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,765.24, has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
The federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $3,880.80 in Firm Fixed Price Delivery Orders for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S to the Defense Logistics Agency (DLA). This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and...
This federal contract award is for pharmaceutical products and medical supplies provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $11,347.43 delivery order contract with the Defense Logistics Agency (DLA) is for Micardis HCT 40-12.5 mg tablets and has a completion date of May 3, 2023. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,003.44 Firm Fixed Price Delivery Order is for the provision of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,572.84 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, with a completion date of February 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a firm fixed price delivery order, is for the provision of Micardis HCT 80-25 mg tablet units. The contract has a ceiling value of $3,524.48 and a performance period through March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,336.09 firm fixed-price delivery order contract is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...